http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. Inhibition of a protein known to contribute to heart failure also appears to be protective of the heart in more acute cardiac stress injury, namely ischemia reperfusion, according to two studies conducted at the Center for Translational Medicine at Thomas Jefferson University. The studies will be presented at the American Heart Association Scientific Sessions 2009 in Orlando, Fla. http://www.physorg.com/news177692193.html Medicine & Health Tue, 17 Nov 2009 15:20:03 EST news177692193 Laboratory experiments have demonstrated the immunological effects of ginseng. Researchers writing in BioMed Central's open access Journal of Translational Medicine have shown that the herb, much used in traditional Chinese and other Asian medicine, does have anti-inflammatory effects. http://www.physorg.com/news161517901.html Medicine & Health Thu, 14 May 2009 11:05:34 EST news161517901 (PhysOrg.com) -- In trying to understand the role of prostaglandins - a family of fatty compounds key to the cardiovascular system - in blood pressure maintenance, researchers at the University of Pennsylvania School of Medicine and colleagues discovered that mice that lack the receptor for one type of prostaglandin have lower blood pressure and less atherosclerosis than their non-mutant brethren. http://www.physorg.com/news159802079.html Medicine & Health Fri, 24 Apr 2009 14:29:12 EST news159802079 A preliminary study on the use of stem cells obtained from a patient's own adipose tissue in the treatment of multiple sclerosis (MS) has shown promising results. The three case studies, described in BioMed Central's open access Journal of Translational Medicine support further clinical evaluation of stromal vascular fraction (SVF) cells in MS and other autoimmune conditions. http://www.physorg.com/news159776574.html Medicine & Health Fri, 24 Apr 2009 07:23:23 EST news159776574 Although cancer remains a leading cause of death in America, it can take up to 12 years to bring a new anti-cancer agent before the FDA and the success rate for approval is only five to 10 percent. That means many research hours and dollars are wasted chasing avenues that will not bring fruit. http://www.physorg.com/news140673617.html Medicine & Health Mon, 15 Sep 2008 05:00:17 EST news140673617